nutrients Review 0 Cytidine 5 -Diphosphocholine (Citicoline): Evidence for a Neuroprotective Role in Glaucoma Stefano Gandolfi 1, Giorgio Marchini 2, Aldo Caporossi 3, Gianluca Scuderi 4 , Livia Tomasso 5 and Andrea Brunoro 5,* 1 Ophthalmology Unit, Department of Biological, Biotechnological and Translational Sciences, University of Parma, Via Gramsci, 14, 43126 Parma, Italy; stefano.gandolfi@unipr.it 2 Ophthalmology Unit, Department of Neurosciences, Biomedicine and Movement, University of Verona, P. le L. A. Scuro, 10, 37134 Verona, Italy;
[email protected] 3 Ophthalmology Unit, Catholic University of the Sacred Heart, Fondazione Policlinico Universitario A. Gemelli, Rome, Italy., Largo F. Vito 1, 00168 Rome, Italy;
[email protected] 4 Ophthalmology Unit, St. Andrea Hospital, NESMOS Department, University of Rome “Sapienza”, Via di Grottarossa 1035/1039, 00189 Rome, Italy;
[email protected] 5 Bausch & Lomb IOM spa Viale Martesana 12, 20090 Vimodrone (MI), Italy;
[email protected] * Correspondence:
[email protected]; Tel.: +39-02-27407331 Received: 6 February 2020; Accepted: 16 March 2020; Published: 18 March 2020 Abstract: Glaucoma, a heterogeneous set of progressively degenerative optic neuropathies characterized by a loss of retinal ganglion cells (RGCs) and typical visual field deficits that can progress to blindness, is a neurodegenerative disease involving both ocular and visual brain structures. Although elevated intraocular pressure (IOP) remains the most important modifiable risk factor of primary open-angle glaucoma (POAG) and is the main therapeutic target in treating glaucoma, other factors that influence the disease course are involved and reaching the optimal IOP target does not stop the progression of glaucoma, as the visual field continues to narrow.